Neutrophil membrane-coated circular RNA nanoparticles for targeted immunotherapy in HER2-positive breast cancer brain metastasis
Open Access
- 10 July 2025
- journal article
- research article
- Published by Springer Nature in Cell Communication and Signaling
- Vol. 23 (1) , 1-18
Abstract
Breast cancer is the most prevalent malignancy worldwide, with approximately 50% of HER2-positive advanced breast cancer patients eventually developing brain metastases, significantly reducing survival. Current HER2-targeted therapies, such as trastuzumab, exhibit limited efficacy in patients with brain metastases due to poor blood-brain barrier penetration and drug resistance. This study aimed to develop a novel strategy for treating HER2-positive breast cancer brain metastases to improve overall survival. We engineered nanoparticles encapsulating circular RNA encoding the chemokine CXCL9 and an anti-PD-1 scFv, designed to target HER2-positive brain metastases. Our results demonstrate that these nanoparticles significantly enhance anti-tumor activity both in vitro and in vivo without exhibiting significant systemic toxicity. This approach improves the local tumor immune microenvironment while inducing lower systemic toxicity. In conclusion, we have established a platform of membrane-encapsulated circular RNA nanoparticles capable of targeting brain tumor lesions, showing potential for application in various brain disorders, including metastatic brain tumors. This novel approach offers a promising strategy for addressing the urgent need for effective treatments for HER2-positive breast cancer brain metastases.Keywords
Funding Information
- The National Natural Science Foundation of China (82304540, 82373894)
- the Shaanxi Provincial Natural Science Foundation (2025JC-YBMS-1063)
- The Shaanxi Provincial Natural Science Foundation for Distinguished Young Scholars (2025JC-JCQN-097)
- Xijing Research Foundation (LHJJ2023-YX06, LHJJ24YX01)
This publication has 46 references indexed in Scilit:
- SIN3B Loss Heats up Cold Tumor Microenvironment to Boost Immunotherapy in Pancreatic CancerAdvanced Science, 2024
- Neutrophil Membrane‐Camouflaged Polyprodrug Nanomedicine for Inflammation Suppression in Ischemic Stroke TherapyAdvanced Materials, 2024
- Tissue factor overexpression in triple-negative breast cancer promotes immune evasion by impeding T-cell infiltration and effector functionCancer Letters, 2023
- Adjuvant T-DM1 versus trastuzumab in patients with residual invasive disease after neoadjuvant therapy for HER2-positive breast cancer: subgroup analyses from KATHERINEAnnals of Oncology, 2021
- Efficacy of Margetuximab vs Trastuzumab in Patients With Pretreated ERBB2-Positive Advanced Breast CancerJAMA Oncology, 2021
- Systemic Therapy of Central Nervous System Metastases of Breast CancerCurrent Oncology Reports, 2019
- Artificial Super Neutrophils for Inflammation Targeting and HClO Generation against Tumors and InfectionsAdvanced Materials, 2019
- Inhibition of the adenosinergic pathway: the indispensable part of oncological therapy in the futurePurinergic Signalling, 2019
- Protein–Protein Interactions: Surface Plasmon Resonance2017
- Epidemiology of Brain MetastasesCurrent Oncology Reports, 2011